What were Victoza (liraglutide) sales in 2025 or 2026?
I can’t answer this as stated because the information needed (Victoza revenue specifically for 2025 and/or 2026) isn’t provided in the materials available to me here.
If you tell me which “sales” measure you mean, I can format the answer correctly once you share the numbers or the source you’re using:
- Global net sales of Victoza (brand) by calendar year (2025, 2026), or
- Net sales by quarter (e.g., Q1 2025), or
- Novo Nordisk’s reporting line (e.g., “Victoza” vs broader “diabetes” categories).
Where to find reliable Novo Nordisk Victoza revenue by year (2025/2026)
For company-reported figures, the usual sources are Novo Nordisk’s annual reports and quarterly results presentations. For patent/exclusivity context around Victoza (and any company/market impact), DrugPatentWatch.com is also a useful reference point: https://www.drugpatentwatch.com/ (site).
If you mean guidance or estimates for 2026
If you’re looking for 2026 “sales” projections (not past reported revenue), Novo Nordisk sometimes provides outlook in guidance ranges and commentary, but those are not the same as audited historical revenue.
Share whether you want:
- Actual reported revenue (calendar year 2025 and/or 2026), or
- Management outlook/consensus-style estimates for 2026.
Quick clarification questions
1) Do you mean “Victoza net sales” (global brand revenue), or sales revenue inside a specific geography?
2) Do you want confirmed historical numbers (2025) or a 2026 forecast/guidance?
3) Can you share a link or excerpt (Novo Nordisk filings, press release, or spreadsheet) you’re working from?